24 Oct 2017 | 12:26 AM
Research Report
Daily

Equity Research Report: Religare Morning Digest

We believe, alignment of Nifty and banking pack would trigger the next directional move else consolidation will endure. Meanwhile, maintain stock specific trading approach and restrict your positions only to the quality names.
03 Feb 2016 | 07:00 AM

    Highlights for Today
 
Market Outlook for the day -We believe, alignment of Nifty and banking pack would trigger the next directional move else consolidation will endure. Meanwhile, maintain stock specific trading approach and restrict your positions only to the quality names.
Key Indices – Levels to watch out for the day
INDEX (Spot) RESISTANCE 2 RESISTANCE 1 LTP SUPPORT 1 SUPPORT 2
SENSEX 25000 24750 24539.00 24375 24200
NIFTY 7600 7525 7455.55 7400 7350
NIFTYBANK 15560 15300 15068.00 14900 14750
NIFTYIT 11480 11360 11242.10 11100 10990
News -
  • The RBI kept its benchmark interest rate viz. the repo rate unchanged at 6.75% after a monetary policy review. The central bank kept the cash reserve ratio (CRR) unchanged at 4% of net demand and time liability (NDTL).
  • Bajaj Auto's total sales during January 2016 have risen by 2% to stand at 2,93,939 units versus 2,88,746 in the same month of 2015. The company's motorcycles sales grew 2% year-on-year to 2,52,988 units (2,46,955 units), while commercial vehicle sales saw a drop of 2% to 40,951 versus 41,791 units.
  • Lupin announced that its US subsidiary has launched its Metformin HCI ER Tablets, 500 mg and 1000 mg in the US.
 
    Trading/ Investment Ideas
Technical Calls
Company
Name
Recommendation CMP Initiation
Range
Stop
loss
Target Time
Frame
PIDILITIND BUY 570.25 564-566 550 600 3-5 Days
CANBK SELL FEB FUT 183.30 184-185 190 172 3-5 Days
 
Derivatives Call
Company
Name
Recommendation CMP Initiation
Price
Stop
loss
Target Time
Frame
SOUTHBANK BUY 20 CE 0.30 0.20 0.05 0.80 3-5 Days
 
Fundamental Picks for delivery ( 9 Months - 1 Year)
Company
Name
Recommendation CMP Initiation
Range
Target
NDL BUY 133.75 150 183
Note – For our running recommendations and past performance, please click here
Research Disclaimer